Sun, Mar 1, 2015, 3:39 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Keryx Biopharmaceuticals Inc. Message Board

  • musketbuzzard musketbuzzard Apr 25, 2012 2:21 PM Flag

    Seeking Theo Rothchilds Opinion

     

    Mr. Rothchild what do you think about the last 2 days activities. Almost 6m traded and down like this. I'm not very experienced at this but, would appreciate your opinion or advice whether on here or email. There are lots of block bids which makes me think they are accumulating.

    Thanks in advance.

    Not interested in hearing from bashers who hide behind anonymity.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Realistically nothing interesting is going to happen with this stock until the turn of 2013 because its going to take time to develop Zerenex. Until then, expect to see a struggle in continuing to develop it, i.e. proving its safety combined with efficacy.

      The latest news release regarding Zerenex offers some minor detail of a study by their Japanese partner in which the objective noted there were no clinically significant findings regarding safety and tolerability. This is an indication that the 12 week study could not address safety to any clinical significance despite it being part of the objective. It may be foretelling of issues to come regarding the relationship between efficacy and safety and execution of a study that can validly address that relationship, and in addition the drug needs to perform within certain boundaries which have yet to be realized.

      Additionally, because most traders and investors are still cognizant of the exaggerated effects of every little pump or bash article on the Perifosine run-up, it's more than likely that any article about KERX is going to cause it to go down unless its an official news release. The news releases themselves are dangerous though because the latest study in Japan specfically notes that it produced no significant clinical findings on safety or tolerance despite it being part of the study objective, however it did come out with top line results on efficacy, but that is simply half the formula and clearly I think there is a lot of work to do on safety. And even if it is safe, it doesn't mean their study will succeed in proving its both safe and effective, at this point its questionable how easy that's going to come along. So its fair to say, it may continue to decline over the next couple months. Then there is the possibility of news regarding trouble with studies which to me is more than likely over this long stretch of time.

      Personally I expect some "pump"/"bash" articles which will be pure nonsense, but will most likely cause the PPS to decline gradually over the months until news of a delay occurs for safety studies.. I have been watching this stock and its management since before the run-up on Perifosine and I think I have a decent idea of how this company operates and what kind of pace they're going to move at.

    • Musketbuzzard, I'm not Theo but the only advice I can give you is to hang on to your position. We are a few months away from results . Demand will build for shares as we approach the end of the year.I believe I've heard Thanksgiving time as the time results will be announced.

      I expect a run into the end of the year to 5 ,pre-announcement.

      Until then ,there's going to be a whole lot of shaking going on.

 
KERX
12.16+0.23(+1.93%)Feb 27 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
PulteGroup, Inc.
NYSEFri, Feb 27, 2015 4:02 PM EST
Clean Energy Fuels Corp.
NASDAQFri, Feb 27, 2015 4:00 PM EST